Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Jim Cramer on Eli Lilly and Company LLY: One Of Our Best Picks For The Charitable Trust

October 30, 2024
Eli Lilly and Company (LLY) has been regarded as one of the top picks for the charitable trust, according to Jim Cramer. The company's strong performance and promising future have made it a reliable investment option, especially in the healthcare sector. With its recent approval of a blockbuster drug and its consistent earnings growth, Eli Lilly continues to attract investors. If you are considering investing in this company, we recommend seeking professional guidance from Stocks Prognosis for accurate stock movement forecasts.
If you want to leave a comment, then you need Login or Register





Other data for LLY

Related data

LLYAugust 12, 2025Eli Lilly and Co LLY Traded Lower in Q2 Despite Good Results  ~1 min.

Eli Lilly and Company, despite reporting good results in the second quarter of this year, saw its stock price traded lower....


LLYAugust 8, 2025ELI LILLY AND COMPANY Stock Hits Price Target Forecast with Profit of 18.31%  ~1 min.

ELI LILLY AND COMPANY stock has successfully achieved the price target forecast set by QuantWave with a profit of 18.31%. The forecast, which indicated a short position on June 4, 2025, at a price of 764....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Forecasted Price Target with 20.09% Profit: QuantWave Achieves Success  ~1 min.

On January 28, 2025, QuantWave, an automated forecasting platform, issued a short signal for ELI LILLY AND COMPANY stock when it was trading at 800.2 $....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits QuantWave Forecast, Delivering 19.57% Profit  ~1 min.

ELI LILLY AND COMPANY has achieved the price target forecast set by QuantWave, signaling a 19.57% profit for investors....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Price Target Forecast as QuantWave Users Gain 17.38% Profit  ~1 min.

ELI LILLY AND COMPANY stock recently achieved the price target forecast set by QuantWave, marking a significant success for users of the automated forecasting platform....


LLYAugust 7, 2025ELI LILLY AND COMPANY Hits Forecast Profit of 23.55%: A Success Story for QuantWave  ~2 min.

ELI LILLY AND COMPANY, a prominent player in the pharmaceutical industry, recently achieved a significant milestone by hitting a price target forecast generated by the innovative forecasting platform, QuantWave. The forecast, which indicated a short direction signal on April 17, 2025, at a price of 836.4 USD, proved to be accurate as the stock reached the predicted target price of 639.46 USD on Au...


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Forecast Price Target with 22.13% Profit - QuantWave Achieves Success in Stock Prediction  ~2 min.

ELI LILLY AND COMPANY stock recently reached the forecast price target set by QuantWave, resulting in a profit of 22.13%....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Price Target Forecast, Generating 17.25% Profit  ~1 min.

ELI LILLY AND COMPANY stock has successfully achieved the price target forecast set by QuantWave, reaching a profit of 17.25%. The forecast signal was issued on April 30, 2024, with the stock price at $772....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Short Price Target Forecast with 19.15% Profit  ~1 min.

On December 24, 2024, QuantWave, the automated forecasting platform, issued a short signal for ELI LILLY AND COMPANY stock when it was priced at 790.94 $....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Price Target Forecast with 22.51% Profit for QuantWave Users  ~2 min.

ELI LILLY AND COMPANY, a prominent pharmaceutical company, recently achieved the price target forecast set by QuantWave, an automated forecasting platform, resulting in a profitable outcome for investors. The forecast signal was generated on 8th November 2024 when the stock was priced at 825.23 $. The prediction indicated a short direction, and on 7th August 2025, the target price of 639.46 $ was ...


LLYOctober 29, 2024LLY: Is Eli Lilly Still a Top Healthcare Stock After Its Blockbuster Drug Approval  ~2 min.

Eli Lilly and Company (NYSE:LLY) has recently received approval for its groundbreaking blockbuster drug, marking a significant milestone for the company....


BIIBJanuary 1, 2025Biogen Inc. (BIIB): A Healthcare Stock with Long-Term Value  ~2 min.

Biogen Inc. (BIIB) is a leading biotechnology company that specializes in developing innovative therapies for neurodegenerative diseases....


MRKNovember 22, 2024Merck & Co. Inc. MRK Sets to Participate in Evercore ISI HealthCONx Conference and Surges Amid Industry Layoff Trends  ~2 min.

Merck & Co. Inc. (MRK), a leading pharmaceutical company, is making significant strides in the healthcare industry....


MRKNovember 10, 2024Merck & Co., Inc. Shares Strategic Insights at UBS Healthcare Conference  ~2 min.

Merck & Co., Inc. (MRK) executives will be presenting at the upcoming UBS Global Healthcare Conference, where they will share strategic insights about the company's future plans and developments....


MRKNovember 7, 2024Merck & Co. Inc. MRK Executives Set to Share Strategic Insights at UBS Healthcare Conference  ~2 min.

Merck & Co. Inc. (MRK) executives are gearing up to participate in the prestigious UBS Global Healthcare Conference, where they will be sharing their strategic insights and plans for the future....